New England Patriots sign DT Jeremiah Pharms Jr
SigningFeb 10, 2026Roster Confirmed
Jeremiah Pharms Jr
DT · New England Patriots
D+
B-
—
Sentiment Analysis
Practice squad defensive tackle signing with minimal immediate impact on roster composition.
Based on media coverage and fan discussion
Contract Value Analysis
The Contract Value Index rates this as a reasonable deal with a CVI ratio of 1.72. Jeremiah projects at average production (62/100) for the DT position. The salary is well below the DT market rate (35/100), contributing to the value profile. At 95/100 on the age-prime scale, Jeremiah is in or near his prime years.
Based on contract structure and market comparables
Contract Value Index
CVI Ratio
1.72Good Value
Performance Score62/100
Salary Efficiency35/100
Age / Prime Window95/100
Contract Length100/100
Guarantee Structure75/100
CVI > 1.0 = team getting more value than paying. CVI < 1.0 = overpay.
Sentiment Breakdown
Sentiment AnalysisNegative
Media Sentiment50/100
FV Move Quality48/100
Coverage Volume70/100
Position Impact70/100
Based on media coverage and fan discussion
Contract Details
Contract details not available.
Fan Verdict
Cast your verdict:
No fan votes yet. Be the first!
Fan Discussion
Loading discussion...
Ad 300x250